A , B , C , D , E , F , G , H , I , J , K , L , M , N , O , P , Q , R , S , T , U , V , W , X , Y , Z
| Kürzel | Test | Einh. | Normalbereich | Hinweis | ||
| LA | La (SS-B) | - | MATERIAL: Serum/Vollblut, METHODE:Immunoblot | |||
| GERIATRIE | Laborprofil GERIATRIE | - | ||||
| LACOSAMID | Lacosamid | ug/ml | 1.00 | - | 10.00 | MATERIAL: Serum/Vollblut METHODE: |
| LACTAT | Lactat | mg/dl | 4.50 | - | 19.80 | MATERIAL: Fluorid-Plasma, METHODE: photometrisch |
| LPQ | Lactat-Pyruvat-Quotient | 0.0 | - | 10.0 | ||
| LACTOFST | Lactoferrin i.St. | ug/g Stuhl | 0.000 | - | 7.240 | MATERIAL: Stuhl |
| LAMBDA | Lambda | mg/dl | 83.00 | - | 224.00 | MATERIAL: Serum/Vollblut, METHODE:turbidimetrisch |
| LAMBM | Lamblien/Giardia IgM | U/ml | 0.0 | - | 30.0 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
| LAMBAG | Lamblien Erregernachweis i.St. | - | MATERIAL: Stuhl, METHODE: mikrosk.Nachw.i.Frischpräp. | |||
| LAMO | Lamotrigin | ug/ml | 3.00 | - | 15.00 | MATERIAL: Serum/Vollblut, METHODE: HPLC |
| LAP | LAP | U/l | 20.00 | - | 50.00 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
| LCMG | LCM IgG | Titer | 0.0 | - | 16.0 | MATERIAL: Serum/Vollblut, METHODE: IFT |
| LCMM | LCM IgM | Titer | 0.0 | - | 16.0 | MATERIAL: Serum/Vollblut, METHODE: IFT |
| LDH | LDH | U/l | 110.0 | - | 243.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
| LDHP | LDH im Punktat | U/l | - | MATERIAL: Punktat, METHODE: photometrisch | ||
| LDH1 | LDH Isoenzym 1 | % | 16.10 | - | 31.50 | MATERIAL: Serum, METHODE: IFE |
| LDH2 | LDH Isoenzym 2 | % | 29.20 | - | 41.60 | MATERIAL: Serum, METHODE: IFE |
| LDH3 | LDH Isoenzym 3 | % | 17.00 | - | 26.20 | MATERIAL: Serum, METHODE: IFE |
| LDH4 | LDH Isoenzym 4 | % | 5.90 | - | 12.30 | MATERIAL: Serum, METHODE: IFE |
| LDH5 | LDH Isoenzym 5 | % | 3.20 | - | 17.30 | MATERIAL: Serum, METHODE: IFE |
| LDHISO | LDH Isoenzyme | - | MATERIAL: Serum, METHODE: IFE | |||
| LDLHDLRAT | LDL/HDL-Ratio | 0.00 | - | 3.50 | ||
| LDL | LDL-Cholesterin | mg/dl | 0.0 | - | 116.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
| LDL_DMP | LDL-Disease Management Programm | mg/dl | - | MATERIAL: Serum/Vollblut, METHODE: photometrisch | ||
| LDL_MDA | LDL MDA-modifiziert | U/l | < | 70.00 | MATERIAL: Serum/Vollblut, METHODE: photometrisch | |
| LDL_OX | LDL oxidiert | ng/ml | < | 133.20 | MATERIAL: Serum/Vollblut, METHODE: photometrisch | |
| LDL_OXAK | LDL oxidiert-AK | - | MATERIAL: Serum/Vollblut, METHODE: | |||
| LDLSUB | LDL-Subfraktionen (Lipoprint) | - | MATERIAL: Serum/Vollblut, METHODE: Gelelektrophorese | |||
| LSCR | Leber-AK Screening | - | MATERIAL: Serum, METHODE: IBLOT | |||
| LEGspezG | Leg.spezies IgG | Titer | 0.0 | - | 255.9 | MATERIAL: Serum/Vollblut, METHODE: IFT |
| LEGG | Legionella pneumophila IgG | - | MATERIAL: Serum/Vollblut, METHODE: EIA | |||
| LEGM | Legionella pneumophila IgM | - | MATERIAL: Serum/Vollblut, METHODE: EIA | |||
| LEG | Legionellen AK | - | ||||
| LEGAGH | Legionellen i.H. | - | MATERIAL: Spontanharn; Methode: EIA | |||
| LEGAG | Legionellen i.Sputum | - | MATERIAL: Sputum; Methode: PCR | |||
| LEISHG | Leishmania donovani IgG-Ak | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
| LEISHM | Leishmania donovani IgM-Ak | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
| LEISHAK | Leishmanien IHA | - | MATERIAL: Serum/Vollblut, METHODE: IHA | |||
| LEPTIN | Leptin | ng/ml | - | MATERIAL: Serum/Vollblut | ||
| LEPTOG | Leptospira IgG | - | MATERIAL: Serum/Vollblut, METHODE: EIA | |||
| LEPTOM | Leptospira IgM | - | MATERIAL: Serum/Vollblut, METHODE: EIA | |||
| LEPTOKBR | Leptospiren KBR | - | MATERIAL: Serum/Vollblut, METHODE: Agg./KBR | |||
| LEUKO | Leukozyten | G/l | 4.00 | - | 10.00 | MATERIAL: EDTA-Blut |
| DIFFP | Leukozytendiff. im Punktat | - | MATERIAL: Punktat | |||
| LEUKOH | Leukozyten i.H. | /ul | 0.0 | - | 0.1 | MATERIAL: Spontanharn |
| LEUKOP | Leukozyten im Punktat | Zahl/ul | - | MATERIAL: Punktat | ||
| LEVETIRA | Levetiracetam | mg/l | 10.00 | - | 40.00 | Material:Vollblut/Serum Methode:HPLC |
| LDOPA | Levodopa (L-Dopa) | mg/l | 0.900 | - | 2.000 | MATERIAL: EDTA-Plasma gefroren, METHODE: HPLC |
| LEVOMEPROM | Levomepromazin | ng/ml | 30.00 | - | 160.00 | MATERIAL: Serum/Vollblut METHODE: |
| LGI1AK | LGI1-AK (IgG) | Titer | 0.00 | - | 10.00 | MATERIAL: Serum, Methode: IFT |
| LH | LH (Luteinisierungshormon) | mIE/ml | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | ||
| LHFSHQ | LH-FSH-Quotient | - | MATERIAL: Spontanharn, METHODE: photometrisch | |||
| LIDOCAIN | Lidocain | mg/l | 1.00 | - | 5.00 | MATERIAL: Serum; METHODE: LC-MS/MS |
| LIGNOCERIN | Lignocerinsäure C24:0 | umol/l | 25.0 | - | 90.0 | MATERIAL: Serum Methode: GC-MS |
| O6_LA | Linolsäure (LA) | mg/l | 945.000 | - | 1516.000 | MATERIAL: Serum/Vollblut |
| LIP | Lipase | U/l | 8.0 | - | 78.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
| LIPELPH | Lipidelphor | - | MATERIAL: Serum/Vollblut, METHODE: Elektrophorese | |||
| LPOX | Lipidperoxidations-Produkte | umol/l | < | 300.000 | MATERIAL: Serum; Methode: HPLC | |
| LIPONSRE | Liponsäure | ug/l | - | MATERIAL: Serum/Vollblut Methode: LC-MS | ||
| LPA | Lipoprotein (a) | nmol/l | 0.0 | - | 75.0 | MATERIAL: Serum/Vollblut, METHODE: Immunologischer Trübungstest |
| LISDEXAMPH | Lisdexamphetamin | ug/l | 1.00 | - | 5.00 | MATERIAL: Serum; METHODE: GC-MS |
| LIST | Listerien IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
| LI | Lithium | mmol/l | - | MATERIAL: Serum/Vollblut, METHODE: ISE | ||
| LKM | LKM (liver/kidney/microsomes) | - | MATERIAL: Serum/Vollblut | |||
| LOPERAMID | Loperamid | ug/l | 1.00 | - | 3.00 | MATERIAL: Serum; METHODE: LC-MS |
| LORAZEPAM | Lorazepam | ug/l | 30.000 | - | 100.000 | MATERIAL: Serum, METHODE: LC-MS |
| IL2REZ | Lösl. Interleukin 2 Rezeptor | U/ml | 158.0 | - | 623.0 | MATERIAL: Serum/Vollblut METHODE: CLIA |
| LRP4AK | LRP4 Antikörper | - | MATERIAL: Serum, METHODE: IFT | |||
| LSDS | LSD (S) | ng/ml | 0.0 | - | 20.0 | MATERIAL: Serum/Vollblut; METHODE: FPIA |
| LSDH | LSD (U) | ng/ml | 0.000 | - | 0.500 | MATERIAL: Spontanharn; METHODE: EMIT |
| TRYPTO | L-Tryptophan | mg/dl | 0.600 | - | 1.900 | MATERIAL: EDTA-Plasma Methode: HPLC |
| LA2 | Lupus-Ak-Bestätigung (SCT) | sec | 31.0 | - | 41.0 | MATERIAL: Citrat, |
| LA1 | Lupus-Ak-Screening (DRVVT) | sec | 31.0 | - | 41.0 | MATERIAL: Citrat, |
| LUP | Lupus eryth. Diagnostik | - | MATERIAL: Citrat, | |||
| IMMUNS | Lympho-Phänotypisierung | - | Material: EDTA, Methode: Flow Cytometrie | |||
| LYP | Lymphozyten | % | - | MATERIAL: Punktat | ||
| LY | Lymphozyten | % | 15.00 | - | 40.00 | MATERIAL: EDTA, |
| LYMPHOA | Lymphozyten (abs.) | /µl | 1000.0 | - | 5500.0 | |
| LYSOZYMST | Lysozym i.St. | ug/g Stuhl | 0.0 | - | 15.0 | MATERIAL: Stuhl, METHODE: ELISA |
| LYSOS | Lysozym im Serum | mg/l | 3.00 | - | 12.00 | MATERIAL: Serum, METHODE: RADIM |